Documents
Document Collection 299 total
| Document ID | Title | Source URL | Type | Auto Tags | Date | Actions | |
|---|---|---|---|---|---|---|---|
55c879d8...
|
Biogen Initiates Phase 3 Study of Felzartamab for ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-06-30 | ||
435a2a20...
|
Instem Taps ex-Novartis Head of Emerging Technolog... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2026-04-15 | ||
e0880120...
|
Pfizer Inc. Earnings Call Q3 2025 | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2025-09-28 | ||
254e2cb6...
|
Vertex Pharmaceuticals Incorporated Earnings Call ... | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2025-09-28 | ||
d5f2542f...
|
Entrada Therapeutics Appoints Maha Radhakrishnan, ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-06-03 | ||
505c4681...
|
Novartis AG Earnings Call Q3 2025 | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2025-09-28 | ||
11cb08a2...
|
U.S. FDA Grants Priority Review to sBLA for PADCEV... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2026-04-20 | ||
4a9b3cad...
|
Eisai Initiated Rolling Supplemental Biologics Lic... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-09-02 | ||
8293ba41...
|
Biogen Inc. Earnings Call Q3 2025 | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2025-09-28 | ||
5afc286c...
|
Novartis IgAN data in New England Journal of Medic... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2026-03-29 | ||
0ce0c234...
|
Jeito Capital Strengthens Leadership for Next Chap... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-05-12 | ||
a8fc8c1a...
|
Biogen and Stoke Therapeutics Announce Publication... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-11-17 | ||
333506cc...
|
Biogen and Stoke Therapeutics Present Data at the ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-09-02 | ||
a5ac1228...
|
FDA Approves New High Dose Regimen of SPINRAZA® (n... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2026-03-30 | ||
88ad6ad1...
|
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for t... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-09-28 | ||
a8629666...
|
Ionis announces Biogen to advance salanersen into ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-06-25 | ||
7d9d4252...
|
Biogen Inc. Earnings Call Q2 2024 | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2024-06-28 | ||
592b7d15...
|
Stoke Therapeutics and Biogen Announce Presentatio... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-08-25 | ||
7e8b4cc4...
|
Anaptys Completes Separation of First Tracks Bioth... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2026-04-20 | ||
3442ff01...
|
Eisai and Biogen Announce U.S. Availability of LEQ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-10-06 |
Showing 41 to 60 of 299 documents